176 related articles for article (PubMed ID: 35385296)
1. Ketohexokinase-mediated fructose metabolism is lost in hepatocellular carcinoma and can be leveraged for metabolic imaging.
Tee SS; Kim N; Cullen Q; Eskandari R; Mamakhanyan A; Srouji RM; Chirayil R; Jeong S; Shakiba M; Kastenhuber ER; Chen S; Sigel C; Lowe SW; Jarnagin WR; Thompson CB; Schietinger A; Keshari KR
Sci Adv; 2022 Apr; 8(14):eabm7985. PubMed ID: 35385296
[TBL] [Abstract][Full Text] [Related]
2. Michaelis-like complex of mouse ketohexokinase isoform C.
Gasper WC; Gardner S; Ross A; Oppelt SA; Allen KN; Tolan DR
Acta Crystallogr D Struct Biol; 2024 Jun; 80(Pt 6):377-385. PubMed ID: 38805243
[TBL] [Abstract][Full Text] [Related]
3. Fructose-induced increases in expression of intestinal fructolytic and gluconeogenic genes are regulated by GLUT5 and KHK.
Patel C; Douard V; Yu S; Tharabenjasin P; Gao N; Ferraris RP
Am J Physiol Regul Integr Comp Physiol; 2015 Sep; 309(5):R499-509. PubMed ID: 26084694
[TBL] [Abstract][Full Text] [Related]
4. Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis.
Shepherd EL; Saborano R; Northall E; Matsuda K; Ogino H; Yashiro H; Pickens J; Feaver RE; Cole BK; Hoang SA; Lawson MJ; Olson M; Figler RA; Reardon JE; Nishigaki N; Wamhoff BR; Günther UL; Hirschfield G; Erion DM; Lalor PF
JHEP Rep; 2021 Apr; 3(2):100217. PubMed ID: 33490936
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of human and mouse ketohexokinase provide a structural basis for species- and isoform-selective inhibitor design.
Ebenhoch R; Bauer M; Romig H; Gottschling D; Kley JT; Heine N; Weber A; Uphues I; Nar H; Pautsch A
Acta Crystallogr D Struct Biol; 2023 Oct; 79(Pt 10):871-880. PubMed ID: 37712434
[TBL] [Abstract][Full Text] [Related]
6. GLUT5 (SLC2A5) enables fructose-mediated proliferation independent of ketohexokinase.
Liang RJ; Taylor S; Nahiyaan N; Song J; Murphy CJ; Dantas E; Cheng S; Hsu TW; Ramsamooj S; Grover R; Hwang SK; Ngo B; Cantley LC; Rhee KY; Goncalves MD
Cancer Metab; 2021 Mar; 9(1):12. PubMed ID: 33762003
[TBL] [Abstract][Full Text] [Related]
7. A splicing switch from ketohexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formation.
Li X; Qian X; Peng LX; Jiang Y; Hawke DH; Zheng Y; Xia Y; Lee JH; Cote G; Wang H; Wang L; Qian CN; Lu Z
Nat Cell Biol; 2016 May; 18(5):561-71. PubMed ID: 27088854
[TBL] [Abstract][Full Text] [Related]
8. HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease.
Mirtschink P; Krishnan J; Grimm F; Sarre A; Hörl M; Kayikci M; Fankhauser N; Christinat Y; Cortijo C; Feehan O; Vukolic A; Sossalla S; Stehr SN; Ule J; Zamboni N; Pedrazzini T; Krek W
Nature; 2015 Jun; 522(7557):444-449. PubMed ID: 26083752
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction.
Gutierrez JA; Liu W; Perez S; Xing G; Sonnenberg G; Kou K; Blatnik M; Allen R; Weng Y; Vera NB; Chidsey K; Bergman A; Somayaji V; Crowley C; Clasquin MF; Nigam A; Fulham MA; Erion DM; Ross TT; Esler WP; Magee TV; Pfefferkorn JA; Bence KK; Birnbaum MJ; Tesz GJ
Mol Metab; 2021 Jun; 48():101196. PubMed ID: 33667726
[TBL] [Abstract][Full Text] [Related]
10. Ketohexokinase knockout mice, a model for essential fructosuria, exhibit altered fructose metabolism and are protected from diet-induced metabolic defects.
Miller CO; Yang X; Lu K; Cao J; Herath K; Rosahl TW; Askew R; Pavlovic G; Zhou G; Li C; Akiyama TE
Am J Physiol Endocrinol Metab; 2018 Sep; 315(3):E386-E393. PubMed ID: 29870677
[TBL] [Abstract][Full Text] [Related]
11. miR-155 down-regulation protects the heart from hypoxic damage by activating fructose metabolism in cardiac fibroblasts.
Zhang Y; Zhang H; Yang Z; Zhang XH; Miao Q; Li M; Zhai TY; Zheng B; Wen JK
J Adv Res; 2022 Jul; 39():103-117. PubMed ID: 35777901
[TBL] [Abstract][Full Text] [Related]
12. Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose.
Futatsugi K; Smith AC; Tu M; Raymer B; Ahn K; Coffey SB; Dowling MS; Fernando DP; Gutierrez JA; Huard K; Jasti J; Kalgutkar AS; Knafels JD; Pandit J; Parris KD; Perez S; Pfefferkorn JA; Price DA; Ryder T; Shavnya A; Stock IA; Tsai AS; Tesz GJ; Thuma BA; Weng Y; Wisniewska HM; Xing G; Zhou J; Magee TV
J Med Chem; 2020 Nov; 63(22):13546-13560. PubMed ID: 32910646
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a Novel Ketohexokinase Inhibitor with Improved Drug Distribution in Target Tissue for the Treatment of Fructose Metabolic Disease.
Zhu G; Li J; Lin X; Zhang Z; Hu T; Huo S; Li Y
J Med Chem; 2023 Oct; 66(19):13501-13515. PubMed ID: 37766386
[TBL] [Abstract][Full Text] [Related]
14. Recent Progress on Fructose Metabolism-Chrebp, Fructolysis, and Polyol Pathway.
Iizuka K
Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049617
[TBL] [Abstract][Full Text] [Related]
15. Fructose Induced KHK-C Increases ER Stress and Modulates Hepatic Transcriptome to Drive Liver Disease in Diet-Induced and Genetic Models of NAFLD.
Park SH; Helsley RN; Fadhul T; Willoughby JLS; Noetzli L; Tu HC; Solheim MH; Fujisaka S; Pan H; Dreyfuss JM; Bons J; Rose J; King CD; Schilling B; Lusis AJ; Pan C; Gupta M; Kulkarni RN; Fitzgerald K; Kern PA; Divanovic S; Kahn CR; Softic S
bioRxiv; 2023 Jan; ():. PubMed ID: 36747758
[TBL] [Abstract][Full Text] [Related]
16. Lacking ketohexokinase-A exacerbates renal injury in streptozotocin-induced diabetic mice.
Doke T; Ishimoto T; Hayasaki T; Ikeda S; Hasebe M; Hirayama A; Soga T; Kato N; Kosugi T; Tsuboi N; Lanaspa MA; Johnson RJ; Kadomatsu K; Maruyama S
Metabolism; 2018 Aug; 85():161-170. PubMed ID: 29604362
[TBL] [Abstract][Full Text] [Related]
17. Bone Growth is Influenced by Fructose in Adolescent Male Mice Lacking Ketohexokinase (KHK).
Williams EAJ; Douard V; Sugimoto K; Inui H; Devime F; Zhang X; Kishida K; Ferraris RP; Fritton JC
Calcif Tissue Int; 2020 May; 106(5):541-552. PubMed ID: 31996963
[TBL] [Abstract][Full Text] [Related]
18. Cell-Type-Specific, Ketohexokinase-Dependent Induction by Fructose of Lipogenic Gene Expression in Mouse Small Intestine.
Al-Jawadi A; Patel CR; Shiarella RJ; Romelus E; Auvinen M; Guardia J; Pearce SC; Kishida K; Yu S; Gao N; Ferraris RP
J Nutr; 2020 Jul; 150(7):1722-1730. PubMed ID: 32386219
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: A randomized phase 2 trial.
Kazierad DJ; Chidsey K; Somayaji VR; Bergman AJ; Birnbaum MJ; Calle RA
Med; 2021 Jul; 2(7):800-813.e3. PubMed ID: 35590219
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin resistance and proinflammatory changes in the visceral adipose tissue induced by fructose consumption via ketohexokinase-dependent pathway.
Marek G; Pannu V; Shanmugham P; Pancione B; Mascia D; Crosson S; Ishimoto T; Sautin YY
Diabetes; 2015 Feb; 64(2):508-18. PubMed ID: 25187370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
